AAAAAA

   
Results: 1-23 |
Results: 23
Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients
Authors: Barker, JN Martin, PL Coad, JE DeFor, T Trigg, ME Kurtzberg, J Weisdorf, DJ Wagner, JE
Citation: Jn. Barker et al., Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients, BIOL BLOOD, 7(7), 2001, pp. 395-399
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
Authors: Arora, M Wagner, JE Davies, SM Blazar, BR Defor, T Enright, H Miller, WF Weisdorf, DJ
Citation: M. Arora et al., Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease, BIOL BLOOD, 7(5), 2001, pp. 265-273
Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997
Authors: Murdych, T Weisdorf, DJ
Citation: T. Murdych et Dj. Weisdorf, Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997, BONE MAR TR, 28(3), 2001, pp. 283-287
Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors
Authors: Barker, JN Weisdorf, DJ Wagner, JE
Citation: Jn. Barker et al., Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors, N ENG J MED, 344(24), 2001, pp. 1870-1871
Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis
Authors: Barker, JN Davies, SM DeFor, T Ramsay, NKC Weisdorf, DJ Wagner, JE
Citation: Jn. Barker et al., Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis, BLOOD, 97(10), 2001, pp. 2957-2961
Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors
Authors: Davies, SM DeFor, TE McGlave, PB Miller, JS Verfaillie, CM Wagner, JE Weisdorf, DJ
Citation: Sm. Davies et al., Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors, AM J MED, 110(5), 2001, pp. 339-346
CMV antigenemia following bone marrow transplantation: Risk factors and outcomes
Authors: Osarogiagbon, RU Defor, TE Weisdorf, MA Erice, A Weisdorf, DJ
Citation: Ru. Osarogiagbon et al., CMV antigenemia following bone marrow transplantation: Risk factors and outcomes, BIOL BLOOD, 6(3), 2000, pp. 280-288
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia
Authors: Davies, SM Ramsay, NKC Klein, JP Weisdorf, DJ Bolwell, B Cahn, JY Camitta, BM Gale, RP Giralt, S Heilmann, C Henslee-Downey, PJ Herzig, RH Hutchinson, R Keating, A Lazarus, HM Milone, GA Neudorf, S Perez, WS Powles, RL Prentice, HG Schiller, G Socie, G Vowels, M Wiley, J Yeager, A Horowitz, MM
Citation: Sm. Davies et al., Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia, J CL ONCOL, 18(2), 2000, pp. 340-347
Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (vol 28, pg 96, 2000)
Authors: Burns, LJ Weisdorf, DJ DeFor, TE Repka, TL Ogle, KM Hummer, C Miller, JS
Citation: Lj. Burns et al., Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer (vol 28, pg 96, 2000), EXP HEMATOL, 28(3), 2000, pp. 352-352
Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer
Authors: Burns, LJ Weisdorf, DJ DeFor, TE Repka, TL Ogle, KM Hummer, C Miller, JS
Citation: Lj. Burns et al., Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer, EXP HEMATOL, 28(1), 2000, pp. 96-103
Response to thalidomide therapy in refractory chronic graft-versus-host disease
Authors: Browne, PV Weisdorf, DJ DeFor, T Miller, WJ Davies, SM Filipovich, A McGlave, PB Ramsay, NKC Wagner, J Enright, H
Citation: Pv. Browne et al., Response to thalidomide therapy in refractory chronic graft-versus-host disease, BONE MAR TR, 26(8), 2000, pp. 865-869
Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation
Authors: Lickliter, JD McGlave, PB DeFor, TE Miller, JS Ramsay, NK Verfaillie, CM Burns, LJ Wagner, JE Eastlund, T Dusenbery, K Weisdorf, DJ
Citation: Jd. Lickliter et al., Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation, BONE MAR TR, 26(7), 2000, pp. 723-728
The spectrum of Malassezia infections in the bone marrow transplant population
Authors: Morrison, VA Weisdorf, DJ
Citation: Va. Morrison et Dj. Weisdorf, The spectrum of Malassezia infections in the bone marrow transplant population, BONE MAR TR, 26(6), 2000, pp. 645-648
Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy
Authors: Lewis, ID Defor, T Weisdorf, DJ
Citation: Id. Lewis et al., Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy, BONE MAR TR, 26(5), 2000, pp. 539-543
Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse
Authors: Brunstein, CG Hirsch, BA Miller, JS McGlennen, RC Verfaillie, CM McGlave, PB Weisdorf, DJ
Citation: Cg. Brunstein et al., Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse, BONE MAR TR, 26(11), 2000, pp. 1173-1177
Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation
Authors: Weisdorf, DJ DeFor, T Nichol, J Panoskaltsis-Mortari, A Blazar, BR
Citation: Dj. Weisdorf et al., Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation, BONE MAR TR, 25(7), 2000, pp. 711-715
Nonmyeloablative HPC transplantation
Authors: Repka, T Weisdorf, DJ
Citation: T. Repka et Dj. Weisdorf, Nonmyeloablative HPC transplantation, TRANSFUSION, 40(7), 2000, pp. 758-760
Haematopoietic cell transplantation in patients with Fanconi anaemia usingalternate donors: Results of a total body irradiation dose escalation trial
Authors: Macmillan, ML Auerbach, AD Davies, SM Defor, TE Gillio, A Giller, R Harris, R Cairo, M Dusenbery, I Hirsch, E Ramsay, NKC Weisdorf, DJ Wagner, JE
Citation: Ml. Macmillan et al., Haematopoietic cell transplantation in patients with Fanconi anaemia usingalternate donors: Results of a total body irradiation dose escalation trial, BR J HAEM, 109(1), 2000, pp. 121-129
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9years' experience of the National Marrow Donor Program
Authors: McGlave, PB Shu, XO Wen, WQ Anasetti, C Nadermanee, A Champlin, R Antin, JH Kernan, NA King, R Weisdorf, DJ
Citation: Pb. Mcglave et al., Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9years' experience of the National Marrow Donor Program, BLOOD, 95(7), 2000, pp. 2219-2225
Infections in recipients of blood and marrow transplantation
Authors: van Burik, JAH Weisdorf, DJ
Citation: Jah. Van Burik et Dj. Weisdorf, Infections in recipients of blood and marrow transplantation, HEMAT ONCOL, 13(5), 1999, pp. 1065
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase
Authors: Gale, RP Park, RE Dubois, RW Herzig, GP Hocking, WG Horowitz, MM Keating, A Kempin, S Linker, CA Schiffer, CA Wiernik, PH Weisdorf, DJ Rai, KR
Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase, LEUK RES, 23(9), 1999, pp. 817-826
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission
Authors: Gale, RP Park, RE Dubois, RW Herzig, GP Hocking, WG Horowitz, MM Keating, A Kempin, S Linker, CA Schiffer, CA Wiernik, PH Weisdorf, DJ Rai, KR
Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission, LEUK RES, 23(8), 1999, pp. 709-718
Risk of lymphoproliferative disorders after bone marrow transplantation: Amulti-institutional study
Authors: Curtis, RE Travis, LB Rowlings, PA Socie, G Kingma, DW Banks, PM Jaffe, WS Sale, GE Horowitz, MM Witherspoon, RP Shriner, DA Weisdorf, DJ Kolb, HJ Sullivan, KM Sobcinski, KA Gale, RP Hoover, RN Fraumeni, JF Deeg, HJ
Citation: Re. Curtis et al., Risk of lymphoproliferative disorders after bone marrow transplantation: Amulti-institutional study, BLOOD, 94(7), 1999, pp. 2208-2216
Risultati: 1-23 |